Goldman Sachs’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,033
Closed -$1.39K 5369
2022
Q4
$1.39K Sell
25,033
-134,400
-84% -$7.47K ﹤0.01% 5087
2022
Q3
$4K Sell
159,433
-200
-0.1% -$5 ﹤0.01% 5352
2022
Q2
$5K Sell
159,633
-6,400
-4% -$200 ﹤0.01% 5595
2022
Q1
$31K Buy
+166,033
New +$31K ﹤0.01% 5548